Literature DB >> 1859761

Cardiac function in aneurysmal subarachnoid haemorrhage: a study of electrocardiographic and echocardiographic abnormalities.

K R Davies1, A W Gelb, P H Manninen, D R Boughner, D Bisnaire.   

Abstract

Electrocardiographic (ECG) changes are reported frequently after subarachnoid haemorrhage (SAH). The aim of this study was to investigate the functional significance of ECG changes by echocardiographic assessment of cardiac function. Forty-five patients with intracranial aneurysms were studied. All patients had a 12-lead ECG and a two-dimensional echocardiogram. After patients with an history of chronic cardiac disease (n = 4) were excluded, only four patients were found to have wall motion abnormalities. These patients had only minor ECG abnormalities, but severe neurological dysfunction. Conversely, patients with other ECG abnormalities including the deep inverted T waves associated usually with SAH, had normal echocardiograms. We conclude that the ECG is not an accurate predictor of myocardial function after SAH and that myocardial dysfunction is related more closely to severity of neurological condition.

Entities:  

Mesh:

Year:  1991        PMID: 1859761     DOI: 10.1093/bja/67.1.58

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  19 in total

Review 1.  Extracerebral organ dysfunction in the acute stage after aneurysmal subarachnoid hemorrhage.

Authors:  Wouter J Schuiling; Paul J W Dennesen; Gabriël J E Rinkel
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage.

Authors:  Avinash Kothavale; Nader M Banki; Alexander Kopelnik; Sirisha Yarlagadda; Michael T Lawton; Nerissa Ko; Wade S Smith; Barbara Drew; Elyse Foster; Jonathan G Zaroff
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

3.  Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage.

Authors:  Jonathan G Zaroff; Ludmila Pawlikowska; Jacob C Miss; Sirisha Yarlagadda; Connie Ha; Achal Achrol; Pui-Yan Kwok; Charles E McCulloch; Michael T Lawton; Nerissa Ko; Wade Smith; William L Young
Journal:  Stroke       Date:  2006-05-25       Impact factor: 7.914

4.  The Risk of Takotsubo Cardiomyopathy in Acute Neurological Disease.

Authors:  Nicholas A Morris; Abhinaba Chatterjee; Oluwayemisi L Adejumo; Monica Chen; Alexander E Merkler; Santosh B Murthy; Hooman Kamel
Journal:  Neurocrit Care       Date:  2019-02       Impact factor: 3.210

5.  Neurogenic pulmonary edema during intracranial endovascular therapy.

Authors:  Randall P Brewer; Cecil O Borel
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

6.  Prevalence and implications of diastolic dysfunction after subarachnoid hemorrhage.

Authors:  Alexander Kopelnik; Landis Fisher; Jacob C Miss; Nader Banki; Poyee Tung; Michael T Lawton; Nerissa Ko; Wade S Smith; Barbara Drew; Elyse Foster; Jonathan Zaroff
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

7.  Preoperative assessment of adult patients for intracranial surgery.

Authors:  Vanitha Sivanaser; Pirjo Manninen
Journal:  Anesthesiol Res Pract       Date:  2010-03-31

Review 8.  Management of aneurysmal subarachnoid hemorrhage.

Authors:  Michael N Diringer
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

Review 9.  Advanced monitoring of systemic hemodynamics in critically ill patients with acute brain injury.

Authors:  Fabio Silvio Taccone; Giuseppe Citerio
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

Review 10.  Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care: a statement for healthcare professionals from the Neurocritical Care Society and the European Society of Intensive Care Medicine.

Authors:  Peter Le Roux; David K Menon; Giuseppe Citerio; Paul Vespa; Mary Kay Bader; Gretchen M Brophy; Michael N Diringer; Nino Stocchetti; Walter Videtta; Rocco Armonda; Neeraj Badjatia; Julian Böesel; Randall Chesnut; Sherry Chou; Jan Claassen; Marek Czosnyka; Michael De Georgia; Anthony Figaji; Jennifer Fugate; Raimund Helbok; David Horowitz; Peter Hutchinson; Monisha Kumar; Molly McNett; Chad Miller; Andrew Naidech; Mauro Oddo; DaiWai Olson; Kristine O'Phelan; J Javier Provencio; Corinna Puppo; Richard Riker; Claudia Robertson; Michael Schmidt; Fabio Taccone
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.